LATITUDE-TIMI: is there still hope for anti-inflammatory therapy in acute myocardial infaction?

about

LATITUDE-TIMI: is there still hope for anti-inflammatory therapy in acute myocardial infaction?

Item

http://www.wikidata.org/entity/Q41428927

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

LATITUDE-TIMI: is there still ...... in acute myocardial infaction?

@en

type

Item

label

LATITUDE-TIMI: is there still ...... in acute myocardial infaction?

@en

prefLabel

LATITUDE-TIMI: is there still ...... in acute myocardial infaction?

@en

P1476

LATITUDE-TIMI: is there still ...... in acute myocardial infaction?

@en

P2093

Ali El-Armouche

http://www.w3.org/2001/XMLSchema#string

Matthias Dewenter

http://www.w3.org/2001/XMLSchema#string

Michael Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of corticosteroid treatment in acute myocardial infarction.

The inflammatory response in myocardial injury, repair, and remodelling.

The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction

Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].

Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease.

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study.

New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease.

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

P304

E1047-E1049

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2016.08.66

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27747059

http://www.w3.org/2001/XMLSchema#string

P932

5059335

http://www.w3.org/2001/XMLSchema#string